Adiponectin and Ethnic Differences in Insulin Resistance
Adiponectin as an Independent Determinant of Ethnic Differences in Insulin Resistance
1 other identifier
observational
43
1 country
1
Brief Summary
The purpose of this protocol is to measure and compare levels of the circulating protein adiponectin and adiponectin's association with insulin sensitivity in Mexican Americans and non-Latino white subjects. The investigators also aimed to examine associations between nutritional factors and adiponectin levels.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 5, 2013
CompletedFirst Posted
Study publicly available on registry
April 15, 2013
CompletedApril 15, 2013
April 1, 2013
5 months
April 5, 2013
April 9, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
total adiponectin concentration
measured once during second study visit, in fasting condition
Secondary Outcomes (1)
Insulin sensitivity
Measured once, during second study visit.
Study Arms (2)
non-Latino white
no Latino ancestry, Caucasian
Mexican American
Mexican American ancestry
Interventions
Eligibility Criteria
Community sample
You may qualify if:
- years of age
- BMI 20.0-34.9 m/kg2
- Mexican American with at least 3 grandparents born in Mexico or white with no grandparents of Latino descent.
You may not qualify if:
- pregnancy
- breastfeeding
- diabetes mellitus
- blood pressure \> 160/100 mmHg
- creatinine \> 1.5 mg/dl or glomerular filtration rate (GFR) \< 60
- liver function tests \> 3x upper limit of normal (ULN)
- h/o heart failure
- h/o eating disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado Anschutz Medical Center
Aurora, Colorado, 80045, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rocio Pereira, MD
University of Colorado, Denver
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2013
First Posted
April 15, 2013
Study Start
March 1, 2011
Primary Completion
August 1, 2011
Study Completion
August 1, 2011
Last Updated
April 15, 2013
Record last verified: 2013-04